Case-Crossover Analysis of Condom Use and Herpes Simplex Virus Type 2 Acquisition

被引:12
作者
Stanaway, Jeffrey D.
Wald, Anna [1 ,2 ,3 ,4 ]
Martin, Emily T. [5 ]
Gottlieb, Sami L. [6 ]
Magaret, Amalia S. [2 ,7 ]
机构
[1] Univ Washington, Harborview Med Ctr, Virol Res Clin, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
[5] Wayne State Univ, Dept Pharm Practice, Detroit, MI USA
[6] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA
[7] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA
基金
美国国家卫生研究院;
关键词
GENITAL HERPES; RISK-REDUCTION; ADOLESCENT POPULATION; INFECTION; TRANSMISSION; PREVENTION; HSV-2; WOMEN; SEROCONVERSION; PARTNERS;
D O I
10.1097/OLQ.0b013e318248aa8a
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although growing evidence suggests that condoms offer moderate protection against herpes simplex virus type 2 (HSV-2), inability to control for unknown or unmeasured confounders associated with sexual activity may reduce the accuracy of the estimates. The case-crossover design offers increased control of individual-level confounders, and was thus used with the aim of producing a more accurate estimate of the effect of condom use on HSV-2 acquisition. Methods: Data were pooled from 6 prospective studies that measured HSV-2 status at enrollment and over follow-up, and included periodic self-reported condom use and sexual activity. Sexual activity contemporaneous with acquisition was assigned to a case period; earlier sexual activity was assigned to a control period. Conditional logistic regression was used to assess differences in behavior during the case and control periods. Results: One hundred ninety-one eligible participants acquired HSV-2 during follow-up. This approach detected a 3.6% increase in the odds of HSV-2 acquisition with each unprotected act (odds ratio = 1.036; 95% confidence interval: 1.021-1.052), but no increase in the odds of acquisition associated with protected acts (odds ratio = 1.008; 95% confidence interval: 0.987-1.030). Conclusions: This analysis suggests that condoms offer significant protection against HSV-2 transmission.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 31 条
  • [1] [Anonymous], 2011, COND STDS FACT SHEET
  • [2] Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection
    Ashley, RL
    Eagleton, M
    Pfeiffer, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) : 1632 - 1633
  • [3] Time course of Seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2
    Ashley-Morrow, R
    Krantz, E
    Wald, A
    [J]. SEXUALLY TRANSMITTED DISEASES, 2003, 30 (04) : 310 - 314
  • [4] Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic
    Austin, H
    Macaluso, M
    Nahmias, A
    Lee, FK
    Kelaghan, J
    Fleenor, M
    Hook, EW
    [J]. SEXUALLY TRANSMITTED DISEASES, 1999, 26 (06) : 329 - 334
  • [5] RISK OF ACQUISITION OF GENITAL HERPES-SIMPLEX VIRUS TYPE-2 IN SEX PARTNERS OF PERSONS WITH GENITAL HERPES - A PROSPECTIVE COUPLE STUDY
    BRYSON, Y
    DILLON, M
    BERNSTEIN, DI
    RADOLF, J
    ZAKOWSKI, P
    GARRATTY, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) : 942 - 946
  • [6] Herpes simplex virus type 2 in prisoners, New South Wales, Australia
    Butler, T
    Donovan, B
    Taylor, J
    Cunningham, AL
    Mindel, A
    Levy, M
    Kaldor, J
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (11) : 743 - 747
  • [7] Casper Corey, 2002, Herpes, V9, P10
  • [8] Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials
    Corey, L
    Langenberg, AGM
    Ashley, R
    Sekulovich, RE
    Izu, AE
    Douglas, JM
    Handsfield, HH
    Warren, T
    Marr, L
    Tyring, S
    DiCarlo, R
    Adimora, AA
    Leone, P
    Dekker, CL
    Burke, RL
    Leong, WP
    Straus, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (04): : 331 - 340
  • [9] Once-daily valacyclovir to reduce the risk of transmission of genital herpes
    Corey, L
    Wald, A
    Patel, R
    Sacks, SL
    Tyring, SK
    Warren, T
    Douglas, JM
    Paavonen, J
    Morrow, RA
    Beutner, KR
    Stratchounsky, LS
    Mertz, G
    Keene, ON
    Watson, HA
    Tait, D
    Vargas-Cortes, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) : 11 - 20
  • [10] Evaluating AIDS prevention interventions using behavioral and biological outcome measures
    Fishbein, M
    Pequegnat, W
    [J]. SEXUALLY TRANSMITTED DISEASES, 2000, 27 (02) : 101 - 110